Heiq Share Discussion Threads

[spectoacc] 02/7/2021 14:03

A buy or a sell tip........ ;)

[pugugly] 02/7/2021 13:52

Much more action than usual - Must have been tipped somewhere - Any knowledge as to the tipster - Was a SCSW but their next issue not due until July 10th

[dr biotech] 01/7/2021 15:48

PE is only 50 if you assume the one off costs I’d listing are repeated, which they won’t be. Still gas a lot to prove - I’m sitting on a moderate loss here and will wait for the next trading update to see how their partnerships are developing.

[pugugly] 01/7/2021 15:16

Still grossly overvaued (IMO) historic p/e 50 - Constant 5 day faller - Masks are probably a red-herring - No real sign of traction.

OK initial hype as sector transformational but very little actionable news (imo)

[geraldus] 01/7/2021 15:03

This is turning into a rout.Needs some big news.

[mmb007] 30/6/2021 11:16

1H numbers should be available mid July, so there should be an update either way from there. Masks are a relatively small % of the earnings so should not really be a share price driver. Key will be the conversion of new customers, acquisitions and Virobloc contracts.

[earwacks] 30/6/2021 10:42

Not only that, some of the cheap brand face masks apparently are next to useless. Trouble is when the share price falls like this its hard to work out if the bigger trades are buys or sells. Initially it looked like share price was falling on small sells but more than normal UT trades too. I think will just have to weather this storm as not bing anything specific, but random trigger of analogue trading.
June 9, 2021
KARMAN, a French supplier of healthcare and hygiene products, has joined forces with HeiQ, to launch the KARMAN ACTIV’PROTECT mask. This disposable Type IIR mask uses HeiQ’s patented HeiQ Viroblock textile technology. This technology gives the textiles of the KARMAN ACTIV’ PROTECT masks safe and permanent antimicrobial and antiviral properties, especially against SARS-CoV-2.
June 22: LIFE’s 40+ products strengthen HeiQ’s global product offering and will facilitate HeiQ’s existing technology platforms into new markets, especially masterbatches, plastics and coatings. Leading manufacturers and brands, such as DuPont, American Standard, Igloo Products, Marks & Spencer, John Lewis, and Columbia Sportswear use LIFE’s antimicrobial additives. Through LIFE, HeiQ will also have access to hygiene technologies, such as odor absorbent additives, that complement HeiQ’s core antimicrobial technology. With the acquisition, HeiQ will now have additional offices and laboratories in Thailand and Brazil.

[melton john] 30/6/2021 10:01

Agree, this isn't a one-trick pony, and in any case, face masks are going to be a feature of life for a long time with mutations and also developing better ones as featured in recent news.

[dr biotech] 30/6/2021 09:47

Like to think any loss of facemasks would be more than compensated by improvements in other textiles. But this is currently friendless.

Probably due a trading update in mid-late July.

[melton john] 30/6/2021 09:23

I just spent an idle 600 quid from a dividend in my ISA. TA indicates it's oversold, on the other hand it could fall through 200 MA.

[earwacks] 30/6/2021 09:05

I guess it only takes 1 seller. Peel Hunt target 2.40. Strange share price reaction to AGM

[edwardt] 30/6/2021 08:11

guess market thinks the covid bounce in face masks will be one off earning hike. i disagree.

[petewy] 16/6/2021 10:49

Acquisition of Life Material Technologies

HeiQ announced the acquisition of Life Material Technologies, Hong Kong, (LIFE) on 15 June, a move which will strengthen its antimicrobial technologies platform. The initial consideration is $6.45m with a potential earn-out consideration payable in 2022 of up to $2.8m. LIFE’s antimicrobial technologies are applicable not only to textiles, with some notable retailers in its customer base, but also to polymers and other coatings, thereby complementing HeiQ’s push into materials beyond textiles and supporting its ambition of becoming a global leader in materials innovation.

[geraldus] 15/6/2021 07:06

Another aquisition in antimicrobial.They want to be world leader.We have got to live with Covid they say.Gla.

[2bluelynn] 09/6/2021 15:42

Nice rise today a few big trades

[petewy] 09/6/2021 09:35

No. Sorry.

[ali47fish] 09/6/2021 08:55

petewy- do you understand why progresive provides this 2 weeks after the announcemnt

[petewy] 09/6/2021 08:21

A note from Progressive Equity Research on two deals:
HeiQ has announced two partnership deals over the past fortnight with Alchemie Technology and Wöllner GmbH. These both deliver more sustainable and environmentally friendly solutions in different industrial sectors, namely textiles, a traditional strength of HeiQ, and industrial water circuits, representing a new market sector.

[impvesta] 28/5/2021 10:16

"petewy28 May '21 - 10:22 - 295 of 295
0 0 0
What announcement?
This was two days ago:
PARTNER NEWS: HeiQ and Alchemie Technology establish sustainable textile finishing partnership"

The RNS was issued this morning:

https://www.investegate.co.uk/heiq-plc--heiq-/rns/creates-sustainable-textile-finishing-partnership/202105280700081092A/

[petewy] 28/5/2021 09:22

What announcement?
This was two days ago:
PARTNER NEWS: HeiQ and Alchemie Technology establish sustainable textile finishing partnership

[melton john] 28/5/2021 08:56

Nice announcement this morning, I worked in textile dyeing once energy costs, water and effluent treatment costs are a huge overhead.

[ali47fish] 28/5/2021 08:51

melton what is wtdik

[melton john] 26/5/2021 09:35

I bought a few early doors, to average down. Charts showed it oversold and quite a few with more appetite for risk piling in now. L2 looks ready for a tick-up but wtfdik.

[pugugly] 21/5/2021 14:43

Jan 27, 2021 Paul Scot at 182p still wildly expensive. Now 169/170
Having studied the Progressive research note (imo) still agree with PS's opinion have not seen anything that would cause me to disagree with the above opinion - Very interesting patent and product portfolio but very little sign, to me, of massivly accelerating revenue growth - Expectations YES but (imo)Jury still out - However if next rns proves on track to beat Progressive's estimates then maybe it could fly.